These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 10485733)
21. F-18 fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory bowel disease. Kresnik E; Mikosch P; Gallowitsch HJ; Heinisch M; Lind P Clin Nucl Med; 2001 Oct; 26(10):867. PubMed ID: 11564929 [No Abstract] [Full Text] [Related]
22. Nuclear medicine imaging of inflammatory bowel disease. Froelich JW Radiol Clin North Am; 1987 Jan; 25(1):133-41. PubMed ID: 3547466 [TBL] [Abstract][Full Text] [Related]
23. [111In-oxine marked leukocytes: a method for diagnosing the location and evaluating the activity of Crohn disease and ulcerative colitis]. Becker W; Fischbach W; Reiners C; Börner W Z Gastroenterol; 1985 Oct; 23(10):557-64. PubMed ID: 3936291 [TBL] [Abstract][Full Text] [Related]
24. Imaging inflammatory bowel disease in the pediatric patient. Stringer DA Radiol Clin North Am; 1987 Jan; 25(1):93-113. PubMed ID: 3823396 [TBL] [Abstract][Full Text] [Related]
25. Barium evaluation of anal canal in patients with inflammatory bowel disease. DuBrow RA; Frank PH AJR Am J Roentgenol; 1983 Jun; 140(6):1151-7. PubMed ID: 6602484 [TBL] [Abstract][Full Text] [Related]
26. [Whole body positron emission tomography (PET) with (18F)-fluorodeoxyglucose]. Grupo PET de la SEMN Rev Esp Med Nucl; 2002 Apr; 21(2):128-30. PubMed ID: 11879625 [No Abstract] [Full Text] [Related]
27. Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations. Gordon BA; Flanagan FL; Dehdashti F AJR Am J Roentgenol; 1997 Dec; 169(6):1675-80. PubMed ID: 9393189 [No Abstract] [Full Text] [Related]
28. Positron emission tomography in cancer patient management. Wahl RL Cancer J Sci Am; 1999; 5(4):205-7. PubMed ID: 10439163 [No Abstract] [Full Text] [Related]
29. [The 75Se homotaurocholic acid test in chronic inflammatory bowel diseases]. Kruis W Z Gastroenterol Verh; 1989 Jul; 24():38-9. PubMed ID: 2474979 [No Abstract] [Full Text] [Related]
30. Preliminary experience of 18F-fluorodeoxyglucose positron emission tomography in Castleman's disease. Robinson H; Prince HM; Ramdave S; Seymour JF; Elliott P; Hicks R Leuk Lymphoma; 2006 Dec; 47(12):2664-6. PubMed ID: 17169817 [No Abstract] [Full Text] [Related]
31. [Gammagraphy with 111In-labelled leukocytes in an acute outbreak of inflammatory intestinal disease. Evaluation of the localization, extension and degree of activity]. Daumal J; Martín-Comín J; Gasull MA; Casanovas T; Roca M; Uribe E; Baliellas C; Ramos M Med Clin (Barc); 1989 Sep; 93(9):325-30. PubMed ID: 2607844 [TBL] [Abstract][Full Text] [Related]
32. Ultrasonography and endosonography in the diagnosis and management of inflammatory bowel disease. Wijers OB; Tio TL; Tytgat GN Endoscopy; 1992 Aug; 24(6):559-64. PubMed ID: 1396365 [No Abstract] [Full Text] [Related]
35. Value of endoscopic ultrasonography in the assessment of inflammatory bowel diseases. Shimizu S; Tada M; Kawai K Endoscopy; 1992 May; 24 Suppl 1():354-8. PubMed ID: 1633780 [TBL] [Abstract][Full Text] [Related]
36. [Inflammatory diseases of the small and large intestine. Comparative use of noninvasive study procedures]. Ruppin H; Hotze A; Bauer J; Lederer P; Matek W; Lux G; Wolf F; Mahlstedt J Fortschr Med; 1986 Jul; 104(27-28):537-40. PubMed ID: 3744264 [No Abstract] [Full Text] [Related]